[1] KURTZ SM, ONG KL, LAU E, et al. Impact of the economic downturn on total joint replacement demand in the united states: Updated projections to 2021. J Bone Joint Surg Am. 2014;96(8):624-630.
[2] SEHAT KR, EVANS RL, NEWMAN JH. Hidden blood loss following hip and knee arthroplasty: Correct management of blood loss should take hidden loss into account. J Bone Joint Surg. 2004;86(4):561-565.
[3] PRASAD N, PADMANABHAN V, MULLAJI A. Blood loss in total knee arthroplasty: An analysis of risk factors. Int Orthop. 2007;31(1):39-44.
[4] BERNARD AC, DAVENPORT DL, CHANG PK, et al. Intraoperative transfusion of 1 u to 2 u packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208(5): 931-937.e2.
[5] BROWNE JA, ADIB F, BROWN TE, et al. Transfusion rates are increasing following total hip arthroplasty: Risk factors and outcomes. J Arthroplasty. 2013;28(8 SUPPL): 34-37.
[6] KATO H, NAKAYAMA T, URUMA M, et al. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history. Vox Sanguinis. 2015;108(3):243-250.
[7] MARRA F, ROSSO F, BRUZZONE M, et al. Use of tranexamic acid in total knee arthroplasty. Joints. 2016;4(4):202-213.
[8] MEENA S, BENAZZO F, DWIVEDI S, et al. Topical versus intravenous tranexamic acid in total knee arthroplasty. J Orthop Surg. 2017;25(1): 2309499016684300.
[9] LIU Y, MENG F, YANG G, et al. Comparison of intra-articular versus intravenous application of tranexamic acid in total knee arthroplasty: A meta-analysis of randomized controlled trials. Arch Med Sci. 2017; 13(3): 533-540.
[10] DEMEY G, SERVIEN E, PINAROLI A, et al. The influence of femoral cementing on perioperative blood loss in total knee arthroplasty: A prospective randomized study. J Bone Joint Surg. 2010;92(3):536-541.
[11] KIM YH, PARK JW, LIM HM, et al. Cementless and cemented total knee arthroplasty in patients younger than fifty five years. which is better. Int Orthop. 2014;38(2):297-303.
[12] BAKER PN, KHAW FM, KIRK L, et al. A randomised controlled trial of cemented versus cementless press-fit condylar total knee replacement: 15-year survival analysis. J Bone Joint Surg. 2007;89(12):1608-1614.
[13] DORWEILER MA, BOIN MA, FROEHLE AW, et al. Improved early postoperative range of motion in total knee arthroplasty using tranexamic acid: A retrospective analysis. J Knee Surg. 2019;32(2): 160-164.
[14] BERRY DJ, BOZIC KJ. Current practice patterns in primary hip and knee arthroplasty among members of the american association of hip and knee surgeons. J Arthroplasty. 2010;25(6):2-4.
[15] KURTZ SM, LAU E, ONG K, et al. Future young patient demand for primary and revision joint replacement: National projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467(10):2606-2612.
[16] DALURY DF. Cementless total knee arthroplasty. Bone Joint J. 2016; 98B(7): 867-873.
[17] MAVROGENIS AF, DIMITRIOU R, PARVIZI J, et al. Biology of implant osseointegration. J Musculoskelet Neur Int. 2009;9(2): 61-71.
[18] CHERIAN JJ, BANERJEE S, KAPADIA BH, et al. Cementless total knee arthroplasty: A review. J Knee Surg. 2014;27(3):193-197.
[19] ZHOU K, YU H, LI J, et al. No difference in implant survivorship and clinical outcomes between full-cementless and full-cemented fixation in primary total knee arthroplasty: A systematic review and meta-analysis. Int J Surg. 2018;53:312-319.
[20] NEWMAN JM, SODHI N, KHLOPAS A, et al. Cementless total knee arthroplasty: A comprehensive review of the literature. Orthopedics. 2018;41(5):263-273.
[21] MAHRINGER-KUNZ A, EFE T, FUCHS-WINKELMANN S, et al. Bleeding in tKA: Posterior stabilized vs. cruciate retaining. Arch Orthop Trauma Surg. 2015;135(6):867-870.
[22] 吴敏. 氨甲环酸配合宫腔水囊治疗前置胎盘剖宫产产后出血的临床效果分析[J]. 世界最新医学信息文摘, 2019, 19(73): 145-146.
[23] 王志焘,张晓东,刁天华. 氨甲环酸灌注治疗复杂胫骨平台骨折术后失血的疗效观察[J]. 蚌埠医学院学报, 2019,44(11):1481-1483.
[24] DAMADE C, TESSON G, GILARD V, et al. Blood loss and perioperative transfusions related to surgery for spinal tumors. relevance of tranexamic acid. Neurochirurgie. 2019;65(6):377-381.
[25] WU GJ, MAZZITELLI BA, QUEK AJ, et al. Tranexamic acid is an active site inhibitor of urokinase plasminogen activator. Blood Adv. 2019;3(5): 729-733.
[26] TZATZAIRIS TK, DROSOS GI, KOTSIOS SE, et al. Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: A randomized controlled study. J Arthroplasty. 2016;31(11): 2465-2470.
[27] SUBRAMANYAM KN, KHANCHANDANI P, TULAJAPRASAD PV, et al. Efficacy and safety of intra-articular versus intravenous tranexamic acid in reducing perioperative blood loss in total knee arthroplasty: A prospective randomized double-blind equivalence trial. Bone Joint J. 2018;100B(2): 152-160.
[28] 陈超, 杨勇, 赵良虎, 等. 氨甲环酸不同给药方式对同期双侧全膝关节置换有效性及安全性研究[J]. 兰州大学学报(医学版), 2019, 45(4):74-77.
[29] GEORGE J, EACHEMPATI KK, SUBRAMANYAM KN, et al. The comparative efficacy and safety of topical and intravenous tranexamic acid for reducing perioperative blood loss in total knee arthroplasty- a randomized controlled non-inferiority trial. Knee. 2018;25(1):185-191.
[30] MI B, LIU G, LV H, et al. Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017;12(1):61.
[31] ABDEL MP, CHALMERS BP, TAUNTON MJ, et al. Intravenous versus topical tranexamic acid in total knee arthroplasty: Both effective in a randomized clinical trial of 640 patients. J Bone Joint Surg Am. 2018;100(12): 1023-1029.
[32] 王高峰. 静脉滴注氨甲环酸对膝关节置换手术患者失血量及血栓性并发症的影响[J]. 中外医疗, 2019, 38(28):61-63.
[33] SPANYER J, PATEL J, EMBERTON E, et al. Topical tranexamic acid in total knee arthroplasty patients with increased thromboembolic risk. J Knee Surg. 2017; 30(5):474-478.
[34] BLOM AW, BROWN J, TAYLOR AH, et al. Infection after total knee arthroplasty. J Bone and Joint Surg Br. 2004;86(5): 688-691.
[35] LI HL, CHAN YC, LI N, et al. Prevalence and predictor of pulmonary embolism in a cohort of chinese patients with acute proximal deep vein thrombosis. Ann Vasc Surg. 2020;63:293-297.
[36] 王涛.低相对分子质量肝素预防膝关节手术后下肢深静脉血栓形成[J].血栓与止血学,2019,25(6):996-997.
[37] 陆靖辉,武建英,杨佳.下肢深静脉血栓的抗凝治疗现状[J].中西医结合心血管病电子杂志,2019,7(29):13+20.
[38] TRONZO RG, KALLOS T, WYCHE MQ. Elevation of intramedullary pressure when methylmethacrylate is inserted in total hip arthroplasty. J Bone Joint Surg. 1974;56(4):714-718.
[39] JEFFERISS CD, LEE AJ, LING RS. Thermal aspects of self-curing polymethylmethacrylate. J Bone Joint Surg Br. 1975;57(4):511-518.
[40] CHARNLEY J. The reaction of bone to self-curing acrylic cement. A long-term histological study in man. J Bone Joint Surg Br. 1970;52: 340-353. |